Skip to main content
ICRweb
About Issuing Certificates

ICR Contents

Regulatory Guidelines
All Contents
  • Fresh Insights Playlist
    • Implementing WHA75.8: Regional clinical trial landscape and strengthening institutional capabilities | ATLAS Webinar May 2026
    • Advancing Pediatric Oncology in Asia: Emerging Strategies in Drug Development and Liquid Biopsy | ATLAS Webinar Jun 2026
    • Precision Medicine in Lung Cancer | ATLAS Webinar Jul 2026
    • US & UK Clinical Trial Environment | ATLAS Webinar Mar 2026
    • Immunotherapy in treatment of locally advanced SCCHN - current paradigms and unmet needs | ATLAS Webinar Apr 2026
    • Precision Treatment and Translational Data Integration for Sarcomas and Rare Cancers | ATLAS Webinar Jan 2026
    • Biliary Tract Cancer (BTC) | ATLAS Webinar Feb 2026
    • 1. DMC Structure and Function by Dr. David DeMets and Dr. James Meaton
    • 2. DMC Case Studies by Dr. James Meaton and Dr. David DeMets
  • Recommended Lectures
    • Cancer Biology and Molecular Biology
    • Sample handling
    • Procedures and Interpretation of Next Generation Sequencing Results
    • Methods of utilizing NGS test results (off-label, clinical trial, etc.)
    • ISO 15189 accreditation program for molecular-genetic laboratories
    • Basic Knowledge and Practical Consideration of Phase I Trials in Oncology
    • The General Role Of CRCs In Cancer Clinical Trials
    • Review of cancer clinical trial protocols from a CRC perspective
    • Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2
    • Designs for clinical trials on cancer - Part 1 of 2
What is ICRweb? What is ATLAS? FAQ Contact

Visitor Counter

ICRweb
  • About ICRweb
  • What is ATLAS?
  • FAQ
  • Contact
  • Japanese
  • Log in
    Sign up

ICRweb: Introduction to Clinical Research (Guest)

Request for Updating your profile
due to site renewal

Thank you for using Introduction to Clinical Research (ICRweb) e-learning site. Please update your profile in order to improve our service to provide better lectures and information that you need.
Time required: Approximately 1 to 2 min.
Update your profile Later....
  • Cancer Genomic Medicine: Essential Course

    ATLAS (Asian clinical TriaLs network for cAncerS) project - Training Program
    Cancer Genomic Medicine Course
    Target trainees: Physicians, laboratory technicians and other relevant professionals who engage or would like to engage cancer genome-based medicine.

    • ATLAS PROJECT
    • The Mission of ATLAS [National Cancer Center Japan Hospital] - YouTube
    • ATLAS project | Facebook
    • ICRweb app is now available in English all over the world!
ICRweb app is now available in English all over the world!
ICRweb app is now available in English all over the world!

For more information about the app, please see here.

The ICRweb User Manual has been prepared.
The ICRweb User Manual has been prepared.
Please download it from the link below if you have any problems while exploring the ICRweb.
DOWNLOAD Link
Skip Latest announcements
Latest announcements
  • 08 Sep 2026
    3 Videos Added to “ATLAS Monthly Webinar 2026” Cours
    NEW
  • 28 Jul 2026
    2 Videos Added to “ATLAS Monthly Webinar 2026” Course
  • 14 Jul 2026
    “ATLAS Monthly Webinar 2026” Now Released on ICRweb
  • 23 Jun 2026
    A New Course Released on Data Monitoring Committee
  • 02 Jun 2026
    One lecture released on a large biobank in Japan
Older topics ...
Skip Fresh Insights Playlist
Fresh Insights Playlist
  • Embark on a learning adventure with our "Fresh Insights Playlist," a curated collection of the latest lectures that promise to spark curiosity and elevate your educational journey. Stay tuned for a dynamic blend of cutting-edge content designed to keep you at the forefront of knowledge.

    • 1:08:13

      Implementing WHA75.8: Regional clinical trial landscape and strengthening institutional capabilities | ATLAS Webinar May 2026

      [Topic] Implementing WHA75.8: Regional clinical trial landscape and strengthening institutional capabilities[Date] 22 May 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Mitsumi Terada(Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)[Lecture 1] 0:06:58~Regional landscape of clinical trial ecosystemsSpeaker: Ms. Mengji Chen(WHO Regional Office for the Western Pacific)[Lecture 2] 0:25:26~WHO Benchmarking Tool for Institutional Capability for Clinical Trials Speaker: Ms. Suzanne Ong(WHO Regional Office for the Western Pacific)[Discussion] 0:44:27~DiscussionFacilitator: Dr. Mitsumi Terada(Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)

      Views1

      User evaluation0.00

      Updated on:22 May 2026 
    • 0:21:58

      Advancing Pediatric Oncology in Asia: Emerging Strategies in Drug Development and Liquid Biopsy | ATLAS Webinar Jun 2026

      [Topic] Advancing Pediatric Oncology in Asia: Emerging Strategies in Drug Development and Liquid Biopsy[Date] 26 June 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Mitsumi Terada(National Cancer Center Hospital, Japan)[Lecture 1] 0:05:52~Current Status of Drug Development in Pediatric Oncology in Japan and the Future Perspectives of the ATLAS Pediatric Oncology GroupSpeaker: Dr. Ayumu Arakawa(National Cancer Center Hospital, Japan)[Lecture 2] We apologize that this lecture is undisclosed according to the lecturer's preference.[Closing Remarks] 0:20:04~Speaker: Dr. Ayumu Arakawa(National Cancer Center Hospital, Japan)

      Views1

      User evaluation0.00

      Updated on:26 June 2026
    • 1:21:37

      Precision Medicine in Lung Cancer | ATLAS Webinar Jul 2026

      [Topic] Precision Medicine in Lung Cancer[Date] 24 July 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Mitsumi Terada(National Cancer Center Hospital, Japan)[Key note] 0:05:38~Precision Medicine in Lung Cancer: The Importance of Biomarker TestingSpeaker: Dr. Voon Pei Jye(Sarawak General Hospital, Malaysia) [Panel talk] 0:36:45~Contrasting genetic testing and treatment access between Malaysia and JapanSpeaker: Dr. Hidehito Horinouchi(National Cancer Center, Japan) [Discussion] 1:01:09~Facilitator: Dr. Mitsumi Terada(National Cancer Center Hospital, Japan)

      Views2

      User evaluation0.00

      Updated on:24 July 2026
    • 1:18:40

      US & UK Clinical Trial Environment | ATLAS Webinar Mar 2026

      [Topic] US & UK Clinical Trial Environment[Date] 12 March 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 0:07:24~Navigating the US Clinical Trial Landscape: Operations, Regulations, and FinancialsSpeaker: Ms. Tomomi Hata(National Cancer Center, Japan)[Lecture 2] 0:32:45~Clinical Research in the UK: The Centralized NHS Model and Evolving Regulatory PathwaysSpeaker: Ms. Celia St Clair(National Cancer Center, Japan)[Discussion] 1:02:35~ DiscussionFacilitator: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)

      Views6

      User evaluation0.00

      Updated on:12 March 2026
    • 0:58:49

      Immunotherapy in treatment of locally advanced SCCHN - current paradigms and unmet needs | ATLAS Webinar Apr 2026

      [Topic] Immunotherapy in treatment of locally advanced SCCHN - current paradigms and unmet needs[Date] 24 April 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Mitsumi Terada(Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)[Lecture 1] 0:05:41~Perioperative immunotherapy in head and neck cancer – hope or hypeSpeaker: Dr. Gopal Iyerw(National Cancer Centre, Singapore)[Lecture 2] 0:23:44~Current Status and Future Directions of Combination Therapy in HNSCC: Strategic Optimization in Locally-Advanced and Recurrent or Metastatic Disease Speaker: Dr. Kao Hsiang Fong(National Taiwan University Hospital, Taiwan)[Discussion] 0:42:11~DiscussionFacilitator: Dr. Mitsumi Terada(Head, Asian Partnerships Section, Department of International Clinical Development, National Cancer Center Hospital, Japan)

      Views5

      User evaluation0.00

      Updated on:24 April 2026
    • 1:11:05

      Precision Treatment and Translational Data Integration for Sarcomas and Rare Cancers | ATLAS Webinar Jan 2026

      [Topic] Precision Treatment and Translational Data Integration for Sarcomas and Rare Cancers[Date] 28 January 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 0:06:25~Precision radiotherapy for sarcomas and other rare cancersSpeaker: Dr. Wong Ru Xin(Icon Cancer Centre, Singapore)[Lecture 2] 0:26:10~Data Integration & Multi-Institutional Efforts for Translational Sarcoma ResearchSpeaker: Dr. Woo Xing Yi(A*STAR Bioinformatics Institute, Singapore)[Discussion] 0:52:13~DiscussionFacilitator: Dr. Valerie Yang Shiwen(OncoCare Cancer Centre, Singapore)

      Views4

      User evaluation5.00

      Updated on:28 January 2026
    • 1:39:20

      Biliary Tract Cancer (BTC) | ATLAS Webinar Feb 2026

      [Topic] Biliary Tract Cancer (BTC)[Date] 26 February 2026 [Opening Remarks] 0:00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 0:08:40~Epidemiology and Clinical Practice of Biliary Tract Cancer in Southeast AsiaSpeaker: Dr. Thanachai Sanlung(Khon Kaen University, Thailand)[Lecture 2] 0:34:14~Current Standard and Future Perspectives of Immunotherapy for BTCSpeaker: Dr. Do-Youn Oh(Seoul National University Hospital, South Korea)[Discussion] 1:13:44~ DiscussionFacilitator: Dr. Li-Tzong Chen(Kaohsiung Medical University Chung-Ho Memorial Hospital, Taiwan)Facilitator: Dr. Chigusa Morizane(National Cancer Center, Japan)

      Views5

      User evaluation5.00

      Updated on:26 February 2026
    • 01:34:17

      1. DMC Structure and Function by Dr. David DeMets and Dr. James Meaton

      In this lecture, the statisticians talk about the history and functions of DMC.0:00:00- [Introduction]0:07:30- [Part I] Data Monitoring Committee Structure & Function0:11:24- [I-A] Brief History of Data Monitoring Committees0:26:25- [I-B] DMCs for Industry-sponsored Trials0:35:57- [I-C] DMC Review Process0:43:45- [I-D] DMC Recommendations0:51:05- [I-E] DMC Membership1:00:05- [I-F] Special Issues1:08:42- [I-G] DMC Meeting Reports1:32:00- [I-H] DMC Summary

      Views3

      User evaluation4.00

      Updated on:6 Apr 2025
    • 01:42:56

      2. DMC Case Studies by Dr. James Meaton and Dr. David DeMets

      In this lecture, the operational aspects of DMC are explained through case studies, and the course is then summarized.0:00:00- [Part II] Data Monitoring Committee Examples0:04:45- Trial Examples0:48:13- DMC Reaffirming Recommendations1:05:36- Trial Examples: External Data1:28:13- Need for Replication1:29:29- Sharing Data1:37:00- Data Lags and Subgroup Findings1:38:41- Importance of Statistical Analysis Center1:39:24- [Part III] Statistical Methods Overview1:39:53- [Summary and Conclusion]

      Views2

      User evaluation4.00

      Updated on:6 Apr 2025
    ‹
    ›
Skip Recommended Lectures
Recommended Lectures
  • The recommended lectures from each course have been picked out. This recommendations help you discover more of the lectures you are interested in.

    • 0:27:38

      Cancer Biology and Molecular Biology

      This content is going to discuss a lecture titled “Cancer Biology and Molecular Biology” for the Cancer Genome-based Medicine Course as part of the presentation series in the ATLAS Training Program.

      Views243

      User evaluation4.55

      Updated on:30 Nov 2021
    • 0:20:50

      Sample handling

      1. Sample Handling Process in Cancer Genomic Medicine2. Tumor Sample Evaluation Procedure3. Examples of Tumor Evaluation4. Tumor Sample Evaluation (Tumor Cell Content)

      Views107

      User evaluation4.40

      Updated on:29 Jun 2021
    • 0:18:06

      Procedures and Interpretation of Next Generation Sequencing Results

      1. Characteristics of gene panel tests and interpretation of the results2. Pathogenic significance of detected mutations3. Mutations and associated therapeutic agents4. Candidate drugs and their evidence levels

      Views80

      User evaluation4.31

      Updated on:9 Jul 2021
    • 0:18:25

      Methods of utilizing NGS test results (off-label, clinical trial, etc.)

      Information on the topics listed on this slide will be presented in the lecture.・Cancer genomic medicine and comprehensive genomic profiling (CGP) test・Treatment based on cancer genomic profiling

      Views83

      User evaluation4.33

      Updated on:12 Dec 2022
    • 0:34:37

      ISO 15189 accreditation program for molecular-genetic laboratories

      1. Efforts for quality assurance in molecular-genetic testing2. Implementation guidance of ISO 15189 for NGS-based tests3. Regional and international efforts to standardize the pre-examination process4. International efforts to standardize multiplex molecular-genetic tests5. Challenges to the EQA/PT program

      Views26

      User evaluation4.00

      Updated on:2 Jun 2021
    • 0:26:04

      Basic Knowledge and Practical Consideration of Phase I Trials in Oncology

      Information on the topics listed on this slide will be presented in the lecture.1. First administration of novel anticancer drugs in human.2. Determining the optimal dose and administration method.3. Dose escalation test using toxicity as an index.

      Views65

      User evaluation4.33

      Updated on:27 Mar 2023
    • 0:40:03

      The General Role Of CRCs In Cancer Clinical Trials

      1. Role of CRC in Cancer Clinical Trials2. Provide Support to Subjects Participating in Cancer Clinical Trials3. Support for conducting Cancer Clinical Trials

      Views51

      User evaluation4.39

      Updated on:23 May 2022
    • 0:28:53

      Review of cancer clinical trial protocols from a CRC perspective

      1. Role and definition of the protocol2. Perspective of CRC reading of the protocol3. Uncomfortable situations when conducting clinical trials4. Summary

      Views40

      User evaluation4.36

      Updated on:24 May 2022
    • 0:18:37

      Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2

      Some key points for interpreting the results of phase III randomized controlled trials are introduced in this lecture. Particularly, this part outlines survival curve and randomization.

      Views54

      User evaluation4.58

      Updated on:20 Sep 2023
    • 0:31:42

      Designs for clinical trials on cancer - Part 1 of 2

      Development flow and clinical trial designs of anticancer drugs are introduced in this lecture. Particularly, this part outlines development flow and phase I clinical trial designs.

      Views31

      User evaluation4.50

      Updated on:20 Sep 2023
    ‹
    ›

Introduction to Clinical Research

  • Top Page
  • What is ICRweb
  • Regulatory Guidelines
  • FAQ
  • Contact Us

Course List

Course List
  • Cancer Genomic Medicine: Essential Course
  • Cancer Genomic Medicine: the Practice in Japan
  • ISO 15189 Accreditation Support Course
  • Phase 1 Trial Development Course
  • CRC Training Course
  • Outline of Clinical Trials on Cancer
  • ATLAS International Symposium
  • SICRES seminar
  • Biostatistics for Clinical Trials on Cancer
  • ATLAS Monthly Webinar 2024
  • ATLAS Monthly Webinar 2025
  • ATLAS Monthly Webinar 2026
  • NCCJ Clinical Research Seminar - DCT and GenAI
  • Introduction of the National Center Biobank Network
  • SCT: Data Monitoring Committees
  • Site Policy

Copyright © 2007-2025 ICRweb all rights reserved.